Tailoring Decisions on Radiation Therapy for DCIS

Decisions about radiotherapy after breast-conserving surgery for ductal carcinoma in situ can be tailored on the basis of patient factors, tumor biology, and the prognostic score, according to research.

Skeletal-related Events Linked With Worse Survival, Increased Costs

Men with prostate cancer and bone metastases that have experienced at least one skeletal-related event (SRE) show worse survival, according to a recent study.

Exercise Intervention Fails to Improve Physical Functioning in Advanced Breast Cancer

Moderate exercise intervention did not appear to improve physical functioning in women with advanced breast cancer to a significant degree, according to study data.

PET Imaging Promising for Metastatic Prostate Cancer

PET Imaging Promising for Metastatic Prostate Cancer

Positron emission tomography (PET) imaging may offer a superior method of imaging for metastatic prostate cancer.

Families of Patients With Cancer Seek Information More Than Support on Internet

Families of patients with cancer are more likely to seek information online than support.

Risk Factors of Suicidal Ideation in Patients With Brain Tumors

A past history of psychiatric disorders has been linked to suicidal ideation in patients with brain tumors.

Vulnerability to Infection Increases for Breast Cancer Survivors Treated With Chemotherapy

Chemotherapy for breast cancer can affect the body's ability to ward off common illnesses.

Treatment Goals Separate From Life Goals Among Patients With Advanced Cancer

Patients with advanced cancer view life goals as distinct from and less important than treatment goals, according to a recent study.

Comprehensive Genetic Profiling Possible for Central Nervous System Tumors

Comprehensive Genetic Profiling Possible for Central Nervous System Tumors

New genetic testing can assist brain cancer treatment planning.

Additional Genes Linked With Ovarian Cancer Risk Identified

The researchers found that nearly one fifth of women with ovarian cancer carried mutations in genes that were associated with ovarian cancer risk beyond the BRCA1 and BRCA2 genes.

Conference Coverage

Targeted Hormone-radiation Treatment Shows Promise in Midgut Neuroendocrine Tumors

Tumor growth may be substantially slowed by the novel therapy 177Lutetium-DOTATATE (Lutathera), according to early results from a phase III study of patients with previously treated, advanced midgut neuroendocrine tumors.

Reduced Toxicity, Similar Efficacy Achieved With Novel Regimen for Advanced Rectal Cancer

No difference in local efficacy was found between two treatment regimens for colorectal cancer: short-course (5-day) radiation followed by consolidation chemotherapy before surgery and standard 5-week chemoradiation.

Lethal Prostate Cancer Risk Lower With Regular Aspirin Use

The risk of lethal prostate cancer, but not of overall, high-grade, or advanced cancers, was reduced with regular aspirin use.

Low-income Breast Cancer Survivors Benefit From Personalized Survivorship Care Plans

Survivorship care plans led to improved outcomes in a randomized, controlled trial reported at the American Society of Clinical Oncology 2016 Cancer Survivorship Symposium.

Adolescent and Young-adult Survivors of Hodgkin Lymphoma May Not Adhere to Follow-up Recommendations

Within the first year posttreatment, more than half of Hodgkin lymphoma survivors did not receive all recommended care. However, 96% had their recommended oncology visits and 70% had the recommended laboratory tests within the first 5 years.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs